AI assistant
Cytek Biosciences, Inc. — Director's Dealing 2023
Aug 22, 2023
32966_dirs_2023-08-21_44f1e33f-01be-4664-b0d0-79c4b47711d1.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cytek Biosciences, Inc. (CTKB)
CIK: 0001831915
Period of Report: 2023-08-18
Reporting Person: Williams Paul Christopher (Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-08-18 | Common Stock | M | 920 | — | Acquired | 1294 | Direct |
| 2023-08-18 | Common Stock | F | 359 | $8.46 | Disposed | 935 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-08-18 | Restricted Stock Units | $ | M | 920 | Disposed | 08/18/2023 (920) | Direct |
Footnotes
F1: Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
F2: Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
F3: The shares subject to the RSU Award shall vest over four years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested.